Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab with Chemoradiotherapy in Poor-Risk Rectal Cancer
NCT01481545Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Dec 2006
- Primary completion
- Jul 2011
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 2 trial of bevacizumab in rectal cancer, sponsored by National Cancer Institute. Started Dec 2006; status: completed.
02
Drugs
bevacizumab
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT01481545.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01481545.